Mogelijk gemaakt door 
Translate
Translate
genedrive plc
("genedrive" or the "Company")
Annual Report and Accounts and date of AGM
genedrive plc (AIM: GDR), the near patient molecular diagnostics company, announces that its 2022 Annual Report and Accounts are now available on the Company's website http://www.genedriveplc.com/investor-relations/company-reports.php . The Notice of the 2022 Annual General Meeting ("AGM") and hard copies of the 2022 Annual Report and Accounts will be posted to shareholders on or around 5 December 2022.
The Company's AGM will be held at 11am on 29 December 2022 at 46 Grafton Street, Manchester M13 9XX.
For further details please contact:
|
genedrive plc |
+44 (0)161 989 0245 |
|
|
David Budd: CEO / Russ Shaw: CFO |
|
|
|
|
|
|
|
|
|
|
|
Peel Hunt LLP (Nominated Adviser and Joint Broker) |
+44 (0)20 7418 8900 |
|
|
James Steel / Oliver Duckworth |
|
|
|
|
|
|
|
|
|
|
|
finnCap (Joint Broker) |
+44 (0)20 7220 500 |
|
|
Geoff Nash / George Dollemore / Nigel Birks / Alice Lane |
|
|
|
|
|
|
|
|
|
|
|
Walbrook PR Ltd (Media Relations & Investor Relations) |
+44 (0)20 7933 8780 or genedrive@walbrookpr.com |
|
|
Paul McManus / Anna Dunphy |
+44 (0)7980 541 893 / +44 (0)7876 741 001 |
|
|
|
|
|
